Plasma exchange for acute attacks of CNS demyelination
Authors:
- S. LlufriuSLS. Llufriu
- J. CastilloJCJ. Castillo
- Y. BlancoYBY. Blanco
- L. Ramió-TorrentàLRL. Ramió-Torrentà
- J. RíoJRJ. Río
- M. VallèsMVM. Vallès
- M. LozanoMLM. Lozano
- M. D. CastellàMCM. D. Castellà
- J. CalabiaJCJ. Calabia
- A. HorgaAHA. Horga
- F. GrausFGF. Graus
- X. MontalbanXMX. Montalban
- 22 September 2009
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 73 (12) , 949-953
Abstract
Background: Plasma exchange (PE) is used to treat severe episodes of CNS demyelination unresponsive to corticosteroids. Predictors of long-term response are not well known. Methods: We retrospectively reviewed the medical records of 41 patients consecutively treated by PE between January 1995 and July 2007. The primary outcome was improvement at 6 months after PE defined as decrease of ≥1 point in the Expanded Disability Status Scale (EDSS) score for patients with EDSS ≤7.5 or 1.5 points with EDSS ≥8.0 or improvement of more than 2 lines in the visual acuity chart for patients with optic neuritis (ON). Results: Twenty-five patients (61%) were women, and the median age was 33 years (range 14–57 years). Twenty-three (56%) had multiple sclerosis, 2 (5%) had clinically isolated syndrome, 2 (5%) had Marburg disease, 7 (17%) had acute disseminated encephalomyelitis, 4 (10%) had neuromyelitis optica, 2 (5%) had idiopathic ON, and 1 (2%) had idiopathic transverse myelitis. The median EDSS score before the attack was 1.0 (range 0–6.5). At PE onset, the median EDSS score was 7.0 (range 3.0–9.5). Sixteen patients (39%) improved at discharge, and 26 (63%) improved at 6 months. In the multivariate analysis, early initiation of PE (odds ratio [OR] 6.29, 95% confidence interval [CI] 1.18–52.96) and improvement at discharge (OR 7.32, 95% CI 1.21–44.38) were significantly associated with response at 6 months. Conclusions: Plasma exchange (PE) was associated with clinical improvement in 63% of patients at 6 months. Early initiation of PE and improvement at discharge were predictors of this response. Twelve patients (48%) who did not improve early did so during follow-up.Keywords
This publication has 18 references indexed in Scilit:
- Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: Review of 50 casesTransfusion and Apheresis Science, 2007
- Plasma Exchange in Neuroimmunological DisordersArchives of Neurology, 2006
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006
- Plasma exchange in episodes of severe inflammatory demyelination of the central nervous systemJournal of Neurology, 2004
- Plasma exchange for severe optic neuritisNeurology, 2004
- Plasmapheresis in acute disseminated encephalomyelitisJournal of Clinical Apheresis, 2004
- Plasmapheresis in fulminant acute disseminated encephalomyelitisNeurology, 1995
- The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosisThe Lancet, 1991
- Double‐blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosisNeurology, 1989
- Rating neurologic impairment in multiple sclerosisNeurology, 1983